CMV pp65 Antibodies

Santa Cruz Biotechnology provides a broad selection of CMV pp65 monoclonal antibodies for various research applications. CMV pp65 monoclonal antibodies excel in techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The CMV pp65 protein, a key component of the cytomegalovirus (CMV) capsid, plays a crucial role in viral replication and pathogenesis. Detection of CMV pp65 is essential for understanding CMV infections, which can lead to significant health issues, particularly in immunocompromised individuals. Studying CMV pp65 enables researchers to gain insights into viral behavior and develop strategies for diagnosis and treatment. CMV pp65 monoclonal antibodies support critical research in viral pathogenesis and immune response mechanisms. Understanding CMV pp65 function and regulation contributes to developing new therapeutic approaches for managing CMV infections. CMV pp65 monoclonal antibodies from Santa Cruz Biotechnology empower researchers worldwide to advance our understanding of viral diseases and potential treatments.